Electroporation System

What is the Electroporation System?

An electroporation system applies controlled electric pulses to transiently permeabilise cell membranes, introducing plasmid DNA, RNA, proteins or CRISPR components into primary cells and hard-to-transfect lines. It is chosen where chemical transfection performs poorly.

Overview

The instrument generates square or exponential pulses with defined voltage, pulse length and number, and applies them across a cuvette or a multi-well electroporation plate. Field strengths of 200–1,500 V/cm for mammalian cells increase membrane permeability for microseconds to milliseconds, allowing charged macromolecules to enter. Modern systems use buffer systems of defined conductivity to reduce arcing, and some use high-frequency pulses or specialised waveforms that improve efficiency in primary and stem cells. Efficiency varies widely by cell type, from a few percent to over 90%, and viability after pulsing typically ranges from 50% to 90%. Optimisation kits with several pulse programmes are supplied so that conditions can be determined for each new cell type.

How does it work?

Each processing step addresses a different physical or biological barrier. Electroporation applies a brief electric pulse that transiently increases membrane permeability so plasmid DNA, RNA or protein can enter the cytoplasm or nucleus; efficiency depends on field strength, pulse shape and buffer conductivity. Thawing instruments warm frozen vials under controlled heat transfer so that cells pass quickly through the temperature range where ice recrystallisation damages membranes. Tissue dissociation combines enzymatic digestion with controlled mechanical shear, using a heater-shaker, a gentleMACS-style rotor or a closed automated chamber, to release single cells while limiting DNA release that causes clumping. Media exchange systems centrifuge, resuspend and wash cells in a closed circuit for concentration and formulation. Vibrating microtomes cut living tissue into slices with minimal damage, preserving neural circuitry for electrophysiology and explant culture.

What are the key features?

• Square-wave and exponential pulse output with programmable parameters
• Field strengths from 200 to 1,500 V/cm for mammalian cells
• Low-conductivity buffers to prevent arcing and heat damage
• Cuvette and multi-well plate chambers for different scales
• Optimisation kits with several pre-set pulse programmes
• Arc detection and pulse monitoring for reproducible delivery

What are the technical specifications?

A typical electroporation system configuration offers voltage range of 10–3,000 V, field strength of 200–1,500 V/cm (mammalian cells), pulse length of 0.01–10 ms, programmable, pulse number of 1–10 with adjustable interval, waveform of Square wave and exponential decay and sample formats of Cuvettes and 24 or 96-well plates. Values are indicative of the product class; the exact figures for each configuration are confirmed on the quotation and the calibration documents supplied with the instrument.

Which applications is it used for?

The Electroporation System is used in transfection of primary immune cells, CRISPR ribonucleoprotein delivery, stem cell and iPSC gene editing and protein and peptide intracellular delivery. Across the wider Cell Processing class, laboratories also deploy it for transfection of primary cells and cell lines, recovery of cryopreserved cell stocks and primary tissue dissociation for cell culture.

Which standards and certifications apply?

Relevant standards and methods include IEC 61010-1, IEC 61010-2-010, IEC 61010-2-020, ISO 20387, USP <1046> and ISO 13485. Certification candidates for this model are CE, ISO 9001 manufacturing and IEC 61010-1 safety; each is to be confirmed for the specific configuration before shipment, and certificates are supplied only where they have been issued.

Keep consumables sterile and single-use where possible, and use aseptic technique for anything that will be cultured. Electroporation cuvettes must be clean and the buffer free of salts that cause arcing; verify pulse delivery by checking the time constant, and monitor temperature because excessive Joule heating kills cells. Dissociation protocols should be stopped as soon as single cells are released, since prolonged enzyme exposure cleaves surface antigens and reduces viability. Cells are sensitive to repeated centrifugation, so minimise steps and use gentle speeds. Validate each new protocol against a reference method, recording recovery, viability and marker expression, and check the quality of tissue slicing with a viability stain such as calcein AM. Maintain temperature-controlled equipment within tolerance and document calibration.

How do I select the right Electroporation System?

Select an electroporation system when chemical transfection is inefficient, when primary or suspension cells are used, or when protein and ribonucleoprotein delivery is required. Specify voltage and pulse range, chamber formats, buffer system and the optimisation support provided for your cell types.

How does it compare with other Cell Processing variants?

Choose by the cell type and the downstream assay. For transfection, compare electroporation with chemical or lipid methods: electroporation suits hard-to-transfect primary cells and suspension lines but needs optimisation of pulse conditions and cell numbers. For tissue work, decide between enzymatic digestion with mechanical shear for solid tissue and gentler dissociation when surface markers or viability are critical. For neural tissue, vibrating microtomes and automated slicers preserve viability better than blade homogenisation. Thawing and media exchange instruments should be selected for closed processing, traceability and reproducibility between operators when regulated workflows are involved. Across all of these, the decisive parameters are sheared-cell percentage, recovery, viability, sterility, sample capacity and the availability of validated protocols for your specific cell type.